Kai Xu

2.4k total citations
119 papers, 1.7k citations indexed

About

Kai Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kai Xu has authored 119 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Kai Xu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), MicroRNA in disease regulation (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Kai Xu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), MicroRNA in disease regulation (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Kai Xu collaborates with scholars based in China, United States and Germany. Kai Xu's co-authors include Wenyi Wei, Pengda Liu, Yingchao Zhao, Jing Yu, Yilong Cheng, Yuxuan Yang, Kaixiang Shen, Xiaodan Zhao, Zheng Liu and Yanfeng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cell and Chemistry of Materials.

In The Last Decade

Kai Xu

109 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Xu China 25 513 346 339 278 180 119 1.7k
Jiwei Wang China 24 556 1.1× 323 0.9× 173 0.5× 263 0.9× 207 1.1× 91 2.1k
Yeon Joo Kim South Korea 21 292 0.6× 287 0.8× 232 0.7× 442 1.6× 208 1.2× 88 1.7k
Yaohui Wang China 21 359 0.7× 333 1.0× 130 0.4× 268 1.0× 272 1.5× 89 1.5k
Juergen Brieger Germany 22 551 1.1× 191 0.6× 305 0.9× 235 0.8× 230 1.3× 50 1.6k
Xiaoxia Hu China 20 511 1.0× 225 0.7× 289 0.9× 89 0.3× 124 0.7× 133 1.7k
Ming You China 27 607 1.2× 264 0.8× 480 1.4× 119 0.4× 283 1.6× 56 2.0k
Xiao‐Long Li China 21 433 0.8× 223 0.6× 165 0.5× 149 0.5× 307 1.7× 81 2.3k
Satoshi Nagano Japan 28 874 1.7× 382 1.1× 169 0.5× 330 1.2× 203 1.1× 120 2.5k

Countries citing papers authored by Kai Xu

Since Specialization
Citations

This map shows the geographic impact of Kai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Xu more than expected).

Fields of papers citing papers by Kai Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Xu. The network helps show where Kai Xu may publish in the future.

Co-authorship network of co-authors of Kai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Xu. A scholar is included among the top collaborators of Kai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Xu. Kai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Dezhi, Yufan Wei, Jun Xu, et al.. (2025). Micro-Raman spectroscopy and Petrography for unraveling the complex heterogeneous physicochemical structures of biochar from the scale of bulk to micro: A comparison and discussion. Journal of Analytical and Applied Pyrolysis. 188. 107057–107057. 5 indexed citations
2.
3.
Liu, Qian, Hao Zheng, Pengwei Zhang, et al.. (2025). Enhancing pyrolysis of automobile shredder residue through torrefaction: Interactions among typical components. Fuel. 390. 134670–134670.
4.
Li, Pengyu, et al.. (2025). Polyacrylonitrile-supported frustrated Lewis pair catalysis of CO2 into cyclic carbonates. Journal of Materials Science. 60(43). 21082–21096.
5.
Tian, Tongguan, Xinxing Li, Kai Xu, et al.. (2025). p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer. Clinical and Translational Medicine. 15(3). e70271–e70271. 6 indexed citations
6.
7.
Li, Kaige, Yang Liu, Xinhua Wang, et al.. (2025). Intermediate Atrial Tachycardia During Persistent Atrial Fibrillation Ablation: A Sub‐analysis of the Extent‐AF Trial. Pacing and Clinical Electrophysiology. 48(4). 455–463. 1 indexed citations
8.
Huang, Hui, et al.. (2024). The Clinical Analysis of Checkpoint Inhibitor Pneumonitis with Different Severities in Lung Cancer Patients: A Retrospective Study. Journal of Clinical Medicine. 13(1). 255–255. 3 indexed citations
9.
Xu, Kai, et al.. (2024). Research on Multi-Layer Defense against DDoS Attacks in Intelligent Distribution Networks. Electronics. 13(18). 3583–3583. 2 indexed citations
10.
Xu, Kai, et al.. (2024). Abnormal detection and early warning mechanism of power market transaction data: a practice and exploration. International Journal of Low-Carbon Technologies. 19. 2010–2017.
11.
Hong, Kai, et al.. (2023). Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy. Frontiers in Immunology. 14. 1228200–1228200. 4 indexed citations
12.
13.
Liu, Jin‐Xin, Yibo Liu, Cuilian Guo, et al.. (2023). MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stability. JCI Insight. 8(9). 4 indexed citations
14.
Xu, Kai. (2022). Mechanism of Negative Emotions of the Elderly in Normalization Period of COVID-19: A Mediated Mediation Model. Frontiers in Public Health. 10. 941958–941958. 2 indexed citations
15.
Huang, Weijia, Jiewei Liu, Kai Xu, Huilin Chen, & Ce Bian. (2022). PD-1/PD-L1 inhibitors for advanced or metastatic cervical cancer: From bench to bed. Frontiers in Oncology. 12. 849352–849352. 25 indexed citations
16.
Xu, Kai, et al.. (2021). An environmental study of tracheostomy on eight COVID-19 patients. Journal of Otolaryngology - Head and Neck Surgery. 50(1). 3–3. 6 indexed citations
17.
18.
Zheng, Shaohui, Min Zhang, Hongyan Bai, et al.. (2019). <p>Preparation of AS1411 Aptamer Modified Mn-MoS<sub>2</sub> QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma</p>. International Journal of Nanomedicine. Volume 14. 9513–9524. 41 indexed citations
19.
Li, Jian, Kathrin Halfter, Mengying Zhang, et al.. (2019). Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signatures. BMC Cancer. 19(1). 600–600. 7 indexed citations
20.
Zhang, Jinfang, Kai Xu, Pengda Liu, et al.. (2016). Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Molecular Cell. 62(6). 929–942. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiwei Wang Breakdown of academic impact, for papers by Yeon Joo Kim Breakdown of academic impact, for papers by Yaohui Wang Breakdown of academic impact, for papers by Juergen Brieger Breakdown of academic impact, for papers by Xiaoxia Hu Breakdown of academic impact, for papers by Ming You Breakdown of academic impact, for papers by Xiao‐Long Li Breakdown of academic impact, for papers by Satoshi Nagano
Rankless by CCL
2026